Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer

Voyager Therapeutics, a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today announced the appointment of Jane Pritchett Henderson as senior vice president and chief financial officer effective January 1, 2017. Ms. … Continue reading

Posted in Executive Appointments, Workplace Diversity | Tagged , , , , , , | Leave a comment

AVROBIO Bolsters Senior Management Team

AVROBIO, a clinical-stage biotechnology company developing transformative cell and gene therapies targeting cancer and rare diseases, has made three senior appointments. Joining the firm’s leadership team are Kim Warren, Head of Operations, Chris Mason, Chief Science Officer, and Deanna Petersen, … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , | Leave a comment

Tocagen Names Vice President

Tocagen, a clinical-stage, cancer-selective gene therapy company, has named John Wood vice president of regulatory affairs and quality assurance. “As Tocagen continues to enroll patients in Toca 5, our Phase 2/3 clinical trial in patients with recurrent high grade glioma, … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , | Leave a comment

Scott Morrison Nets Two Board Appointments

Scott Morrison, a retired Ernst & Young Partner, was appointed to the board of directors at Audentes Therapeutics and Global Blood Therapeutics.Watch Full Movie Online Streaming Online and Download Audentes Therapeutics is a San Francisco-based biotechnology company committed to the … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

Board Appointment for IPO-ready Dimension Therapeutics

Just days after setting the terms for its pending IPO, Dimension Therapeutics, Inc., a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders,  announced the election of Alan B. Colowick, M.D., M.P.H., Executive Vice President of Celgene … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , , | Leave a comment

Dimension Therapeutics Diversifies Leadership with Management and Board Appointment

Dimension Therapeutics, a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders has announced that it has expanded its Board of Directors with the elections of Georges Gemayel, Ph.D., former Executive Vice President of Genzyme Corporation, and Arlene M. … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Executive and Board Director Appointments in Oncology and Rare Diseases

Third Rock Ventures portfolio company, Voyager Therapeutics, a gene therapy player in the field of CNS based out of Cambridge, Mass. have appointed Michael Higgins to the Board of Directors. Mr. Higgins is an experienced biotechnology executive and is currently an … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Astellas joins with Harvard for Gene Therapy push

Authored by James Sheppard The Japanese pharmaceutical giant Astellas announced that it was making its first efforts in the promising field of gene therapy. Astellas announced that it has signed a deal with Harvard Medical School investigator Constance Cepko to … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Avalanche Biotechnologies raises $102m in up-sized IPO

Authored by James Sheppard The California based gene therapy company Avalanche Biotechnologies announced that it has raised $102m from its initial public offering (IPO). The company will be listed on the NASDAQ under the ticker symbol AAVL. Avalanche develops gene … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , | Leave a comment

Gene Therapy used to create biological pacemakers

Authored by James Sheppard A team of cardiologists at the Cedars-Sinai Heart Institute in Los Angeles, California have created biological pacemaker cells that can keep the heart steadily beating. The cells have been created through gene transplant that is minimally … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap